only issue is that the company only really has one product that will be open for more competition soonish!. little or no r&d for new products last 12 months per annual report and what is happening now - not much IMO from information that has been released. company needs to provide more income streams and other products - no reason not to as it is cashed up - why save the money - to keep operated costs including wages payments being able to be met longer??. IMO thats the perceived weakness here - as one poster once said "a one trick pony" which means that it is obviously going to have issues as generic brands are marketed in the future. happy to be corrected but give me old management any day!
ACR Price at posting:
$2.27 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)